Meta Pixel

News and Announcements

QBiotics Share Offer Oversubscribed by $4.3m

  • Published October 12, 2016 3:30PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Long term Axstra client QBiotics Limited has successfully raised in $16.8 million from its latest round of capital raising. The Company’s Prospectus Share Offer was oversubscribed by $4.3m following high demand from investors. In light of the interest in QBiotics, a Private Placement was also successfully implemented.

The new capital places QBiotics in a strong financial position moving forward with over AU$30 million in the bank. Current emphasis is on finalising product development and market launch preparation of the anticancer drug EBC-46 for the USA and UK veterinary market, and development of QBiotics’ wound healing treatment WH-1 for human diabetic foot ulcers and venous leg ulcers.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now